The story of Viagra, and its creator copyright, presents a intriguing case study for investors. Initially a blockbuster drug, producing billions in revenue , its exclusivity period created a wave of lower-priced alternatives , significantly eroding its position . While some firms may try to capitalize on related treatments , the present landscape d